Salmonellosis medical therapy: Difference between revisions

Jump to navigation Jump to search
Line 32: Line 32:


===2nd Line Antibiotics===
===2nd Line Antibiotics===
===Multidrug Resistance===
Some serovars of ''Salmonella enterica'', particularly Typhimurium and Newport, are linked to more severe cases of salmonellosis and multi-drug resistance.<ref name="pmid25136336">{{cite journal| author=Gal-Mor O, Boyle EC, Grassl GA| title=Same species, different diseases: how and why typhoidal and non-typhoidal Salmonella enterica serovars differ. | journal=Front Microbiol | year= 2014 | volume= 5 | issue=  | pages= 391 | pmid=25136336 | doi=10.3389/fmicb.2014.00391 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25136336  }} </ref>


==Follow Up==
==Follow Up==

Revision as of 17:25, 20 August 2014

Salmonellosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Salmonellosis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Treatment

Medical Therapy

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Salmonellosis medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Salmonellosis medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Salmonellosis medical therapy

CDC on Salmonellosis medical therapy

Salmonellosis medical therapy in the news

Blogs on Salmonellosis medical therapy

Directions to Hospitals Treating Salmonellosis

Risk calculators and risk factors for Salmonellosis medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2] Jolanta Marszalek, M.D. [3]

Overview

Medical Therapy

Treatment of salmonellosis is often symptomatic, with electrolyte replacement and rehydration. Mild cases of salmonelloses usually resolve within 5 to 7 days. Patients with severe cases of the disease may require rehydration, often with intravenous fluids. Antibiotic treatment is not routinely recommended, unless the patient becomes severely dehydrated or infection reaches the blood stream.[1]

Salmonellosis commonly presents with unspecific gastrointestinal symptoms, such as diarrhea, fever, and abdominal pain. Antibiotic treatment of infectious diarrhea is considered controversial because:[2]

  • Symptoms may be caused by different types of enteric pathogens, which makes the initial treatment of severe cases often "empiric"
  • Antibiotic treatment of non-typhoidal salmonellosis prolongs shedding of the bacteria in feces.

Antibiotic Therapy

Antibiotic therapy is indicated for patients with severe cases of the disease, and for those with risk factors of extra intestinal infection, after blood and fecal cultures have been obtained. Risk groups for the development of extra-intestinal manifestations include:[2][3]

Antibiotic treatment may be indicated in cases when rapid interruption of fecal shedding of the bacteria is required to avoid outbreaks in institutions.[4]

1st Line Antibiotics

2nd Line Antibiotics

Multidrug Resistance

Some serovars of Salmonella enterica, particularly Typhimurium and Newport, are linked to more severe cases of salmonellosis and multi-drug resistance.[3]

Follow Up

Fecal cultures are not indicated for patient follow-up after uncomplicated cases of salmonellosis, irrespectively to the treatment administrated. The results tend to be intermittently positive for a long period of time, and do not show any utility in an asymptomatic patient.[2][5]

References

  1. "Salmonella (non-typhoidal)".
  2. 2.0 2.1 2.2 Hohmann EL (2001). "Nontyphoidal salmonellosis". Clin Infect Dis. 32 (2): 263–9. doi:10.1086/318457. PMID 11170916.
  3. 3.0 3.1 Gal-Mor O, Boyle EC, Grassl GA (2014). "Same species, different diseases: how and why typhoidal and non-typhoidal Salmonella enterica serovars differ". Front Microbiol. 5: 391. doi:10.3389/fmicb.2014.00391. PMID 25136336.
  4. Lightfoot NF, Ahmad F, Cowden J (1990). "Management of institutional outbreaks of Salmonella gastroenteritis". J Antimicrob Chemother. 26 Suppl F: 37–46. PMID 2292544.
  5. Buchwald DS, Blaser MJ (1984). "A review of human salmonellosis: II. Duration of excretion following infection with nontyphi Salmonella". Rev Infect Dis. 6 (3): 345–56. PMID 6377442.

Template:WikiDoc Sources